CLOV
Get informed when a big investor buys or sells
+ FollowOvervalued by 194.7% based on the discounted cash flow analysis.
| Market cap | $2.06 Billion |
|---|---|
| Enterprise Value | $1.89 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.17 |
| Beta | 2.45 |
| Outstanding Shares | 522,184,385 |
| P/E Ratio | -36.5 |
|---|---|
| PEG | 1.63 |
| Price to Sales | 0.91 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.86 |
| Enterprise Value to EBIT | -33.18 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5787▼ 9.52% |
|---|---|
| Total Calls | 4,327,000▼ 29.62% |
| Total Puts | 2,503,900▼ 39.57% |
Holdings and activity of institutional investors.
| Ownership % | 24.64%▲ 0.02% |
|---|---|
| Total Invested | $224.59M▼ 24.31% |
| Investors Holding | 218▲ 11.00% |
No data
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outco...